7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
      
    		               
      operating activities:
    		               
      net income
    		-25,176,000 -27,891,000 -32,482,000 -35,188,000 -38,676,000 -34,383,000 -35,054,000 -37,137,000 -35,373,000 -37,371,000 -35,598,000 -31,348,000 -26,006,000 -23,193,000 -15,638,000 
      adjustments to reconcile net income to net cash from operating activities:
    		               
      depreciation and amortization
    		538,000 538,000 538,000 536,000 536,000 530,000 518,000 540,000 518,000 506,000 559,000 538,000 538,000 276,000 129,000 
      accretion of discount on available-for-sale securities
    		-1,137,000     -417,000 -111,000 221,000 380,000  454,000 300,000 180,000   
      stock-based compensation
    		4,660,000 4,367,000 4,549,000 4,660,000 4,607,000 4,833,000 4,911,000 4,520,000 4,252,000 4,355,000 4,428,000 4,517,000 2,962,000 1,991,000 1,471,000 
      reduction in the carrying amount of right-of-use assets
    		308,000 296,000 285,000 274,000 264,000 488,000 248,000 239,000 230,000 347,000 416,000     
      changes in operating assets and liabilities:
    		               
      prepaid expenses and other current assets
    		-1,629,000 -191,000 725,000 -252,000 1,070,000 -183,000 -1,480,000 817,000 383,000 -847,000 -2,124,000 1,422,000 -1,063,000 84,000 -1,982,000 
      other non-current assets
    		-361,000      814,000 -777,000 -241,000       
      accounts payable
    		-1,531,000 426,000 -2,351,000 -3,187,000 3,035,000 490,000 -3,446,000 884,000 1,785,000 2,985,000 832,000 -742,000 784,000 -220,000 946,000 
      accrued liabilities
    		-3,378,000 -480,000 1,537,000 -1,724,000 -2,771,000 2,137,000 3,305,000 2,596,000 -1,860,000 592,000 828,000 71,000 -718,000 1,848,000 1,531,000 
      operating lease liabilities
    		-570,000 -153,000 -506,000 -496,000 -348,000 -848,000 -429,000 -42,000 -412,000 654,000 490,000     
      other current liabilities
    		9,000 -129,000 9,000 -223,000 204,000 10,000 6,000 -25,000 50,000       
      net cash from operating activities
    		-28,267,000 -23,477,000 -28,291,000 -36,381,000 -32,993,000 -27,139,000 -30,718,000 -28,164,000 -30,288,000 -28,321,000 -29,715,000 -24,658,000 -23,416,000 -19,256,000 -13,584,000 
      capex
    		0 -7,000 -20,000 -28,000 -132,000 -290,000 -144,000 -861,000 -4,413,000 -855,000 -803,000 0 -32,000 -172,000 -276,000 
      free cash flows
    		-28,267,000 -23,484,000 -28,311,000 -36,409,000 -33,125,000 -27,429,000 -30,862,000 -29,025,000 -34,701,000 -29,176,000 -30,518,000 -24,658,000 -23,448,000 -19,428,000 -13,860,000 
      investing activities:
    		               
      purchases of property and equipment
    		 -7,000 -19,000 -30,000 -137,000 -282,000 -169,000 -861,000 -5,214,000 -855,000 -767,000 0 -32,000 -172,000 -276,000 
      purchases of available-for-sale securities
    		-100,302,000 -24,476,000 -13,737,000 -38,440,000 -31,435,000 -66,833,000 -18,732,000 -21,697,000 -5,935,000 -34,479,000 -31,506,000 -117,067,000 -42,549,000   
      proceeds from maturities of available-for-sale securities
    		23,000,000 22,300,000 61,594,000 44,001,000 51,089,000 23,500,000 32,999,000 42,267,000 79,400,000 71,026,000 29,000,000 28,000,000 5,000,000   
      net cash from investing activities
    		-77,302,000 -2,183,000 47,838,000 5,531,000 19,517,000 -43,615,000 14,098,000 19,709,000 68,251,000 33,697,000 -1,278,000 -83,074,000 -37,581,000 -82,872,000 -276,000 
      financing activities:
    		               
      proceeds from the exercise of common stock options
    		198,000 -21,000 0 0 111,000     486,000      
      proceeds from the issuance of common stock, including related party of zero and 17,995 for the three months ended march 31, 2024 and 2023, respectively
    		33,131,000               
      payment of financing costs
    		-917,000               
      net cash from financing activities
    		32,412,000 117,598,000 0 345,000 17,581,000 108,000 122,668,000 113,000 19,000 948,000 -73,000 652,000 268,000 0 259,781,000 
      increase in cash, cash equivalents and restricted cash
    		-73,157,000 91,938,000 19,547,000 -30,505,000 4,105,000 -70,646,000 106,048,000 -8,342,000 37,982,000       
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-12,000 13,000 -2,000 -1,000 -5,000 8,000 -4,000 -6,000 3,000 0 -3,000 -1,000 -1,000   
      cash, cash equivalents and restricted cash
    		               
      beginning of period
    		226,142,000 0 0 0 141,052,000 0 0 0 76,009,000  0 0 268,565,000   
      end of period
    		152,973,000 91,951,000 19,545,000 -30,506,000 145,152,000 -70,638,000 106,044,000 -8,348,000 113,994,000  -31,069,000 -107,081,000 207,835,000   
      supplemental disclosure of cash flow information:
    		               
      cash paid for amounts included in the measurement of lease liability
    		1,216,000 1,203,000 1,175,000 1,175,000 1,175,000 7,050,000 1,136,000 757,000 1,135,000 0 252,000     
      non-cash investing and financing activities:
    		               
      deferred offering costs included in accounts payable and accrued liabilities
    		117,000               
      purchases of property and equipment included in accounts payable and accrued liabilities
    		  -1,000 2,000 5,000 -8,000 25,000         
      accretion of (discount) premium on available-for-sale securities
    		 -260,000 -595,000             
      proceeds from employee stock purchase plan purchases
    		 134,000 0             
      proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of 17,995 and 9,500 for the years ended december 31, 2023 and 2022, respectively
    		               
      proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of 948, net of commissions
    		               
      other assets
    		    -12,000           
      proceeds from the issuance of common stock to a related party, net of commissions
    		  0 0 17,545,000           
      payment of common stock issuance costs
    		  0 0 -75,000           
      proceeds from the issuance of common stock, pre-funded warrants and common warrants in private placement
    		               
      proceeds from the issuance of common stock, pre-funded warrants and common warrants in private placement - related party
    		               
      payment of common stock, pre-funded warrants and common warrants issuance costs related to private placement
    		               
      deferred offering costs included in accrued liabilities
    		               
      accretion of premium (discount) on available-for-sale securities
    		    -902,000           
      proceeds from sale of available-for-sale-securities
    		               
      proceeds from employee stock plan purchases
    		     227,000 0    0     
      proceeds from the issuance of common stock, pre-funded warrants and common warrants
    		     0          
      proceeds from the issuance of common stock, pre-funded warrants and common warrants - related party
    		     0          
      payment of issuance costs related to the issuance of common stock, pre-funded warrants and common warrants
    		     -135,000          
      right-of-use assets obtained in exchange for lease liability
    		         0 0     
      construction-in-progress obtained in exchange for tenant improvement allowance from lessors
    		          6,918,000     
      proceeds from the exercise common stock options
    		      45,000 0 19,000   534,000 268,000   
      deferred offering costs payment related to the 2021 atm program
    		               
      purchases of property and equipment included in accrued liabilities
    		        801,000       
      accretion of discount on available-for sale securities
    		               
      other long-term assets
    		             0 52,000 
      deferred rent
    		            -93,000 -95,000 -93,000 
      proceeds from sale of available-for-sale securities
    		         -1,995,000 1,995,000     
      proceeds from employee stock purchase plan
    		               
      proceeds from paycheck protection program loan
    		             0 0 
      repayments of paycheck protection program loan
    		             0 0 
      proceeds from issuance of redeemable convertible preferred stock
    		             0  
      payments of issuance costs related to redeemable convertible preferred stock
    		             0  
      proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions
    		             0  
      payments of offering costs related to initial public offering
    		             0  
      increase in cash, cash equivalents, and restricted cash
    		         6,324,000      
      cash, cash equivalents, and restricted cash at beginning of year
    		               
      cash, cash equivalents, and restricted cash at end of year
    		               
      supplemental disclosures of cash flow information:
    		               
      reclassification of redeemable convertible preferred stock to common stock upon initial public offering
    		             0  
      accretion on redeemable convertible preferred stock
    		             0 145,000 
      leasehold improvements obtained in exchange for tenant improvement allowance from lessors
    		               
      purchase of property and equipment included in accounts payable and accrued liabilities
    		               
      beneficial conversion feature recognized upon issuance of redeemable convertible preferred stock
    		             0 0 
      deemed dividend arising from conversion of beneficial conversion feature
    		             0  
      deferred offering costs payment
    		               
      purchase of property and equipment included in accounts payable
    		          -36,000     
      deferred offering cost payments
    		               
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		               
      net increase in cash, cash equivalents and restricted cash
    		               
      issuance costs of redeemable convertible preferred stock included in accounts payable and accrued liability
    		               
      net decrease in cash, cash equivalents and restricted cash
    		            -60,729,000   
      change in fair value of redeemable convertible preferred stock liability
    		               
      purchase of available-for-sale securities
    		               
      net increase in cash and cash equivalents
    		             -102,128,000 245,921,000 
      effect of exchange rate changes on cash and cash equivalents
    		             7,000 4,000 
      cash and cash equivalents at beginning of period
    		             0 0 
      cash and cash equivalents at end of period
    		             -102,121,000 245,925,000 
      income taxes paid
    		               
      reclassification of redeemable convertible preferred stock liability to redeemable convertible preferred stock
    		               
      payment of deferred offering costs
    		               
      issuance costs of redeemable convertible preferred stock included in accounts payable and accrued liabilities
    		               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.